Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,931 articles, preprints and more)

Search results

1-25 of 30 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Author Correction: Structural basis for partial agonism in 5-HT_3A receptors.
Felt K, Stauffer M, Salas-Estrada L, Guzzo PR, Xie D, Huang J, Filizola M, Chakrapani S
Nat Struct Mol Biol, 31(4):728, 01 Apr 2024
Cited by: 1 article | PMID: 38580848
Add to export list
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.
Zhou Y, Börcsök J, Adib E, Kamran SC, Neil AJ, Stawiski K, Freeman D, Stormoen DR, Sztupinszki Z, Samant A, Nassar A, Bekele RT, Hanlon T, Valentine H, Epstein I, Sharma B, Felt K, Abbosh P, Wu CL, [...] Mouw KW
Sci Adv, 9(47):eadg2263, 22 Nov 2023
Cited by: 3 articles | PMID: 37992168 | PMCID: PMC10664985
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Structural basis for partial agonism in 5-HT_3A receptors.
Felt K, Stauffer M, Salas-Estrada L, Guzzo PR, Xie D, Huang J, Filizola M, Chakrapani S
Nat Struct Mol Biol, 31(4):598-609, 04 Jan 2024
Cited by: 1 article | PMID: 38177669
Add to export list
Systematic benchmarking of imaging spatial transcriptomics platforms in FFPE tissues
Wang H, Huang R, Nelson J, Gao C, Tran M, Yeaton A, Felt K, Pfaff KL, Bowman T, Rodig SJ, Wei K, Goods BA, Farhi SL
bioRxiv, 08 Dec 2023
Cited by: 0 articles | PPR: PPR771508
Add to export list Preprint
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states.
Nyman J, Denize T, Bakouny Z, Labaki C, Titchen BM, Bi K, Hari SN, Rosenthal J, Mehta N, Jiang B, Sharma B, Felt K, Umeton R, Braun DA, Rodig S, Choueiri TK, Signoretti S, Van Allen EM
Cell Rep Med, 4(9):101189, 01 Sep 2023
Cited by: 4 articles | PMID: 37729872 | PMCID: PMC10518628
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.
Ricciuti B, Elkrief A, Alessi J, Wang X, Li Y, Gupta H, Muldoon DM, Bertram AA, Pecci F, Lamberti G, Di Federico A, Barrichello A, Vaz VR, Gandhi M, Lee E, Shapiro GI, Park H, Nishino M, Lindsay J, [...] Cheng ML
Clin Cancer Res, 29(13):2540-2550, 01 Jul 2023
Cited by: 3 articles | PMID: 37097610
Add to export list
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.
Alessi JV, Wang X, Elkrief A, Ricciuti B, Li YY, Gupta H, Spurr LF, Rizvi H, Luo J, Pecci F, Lamberti G, Recondo G, Venkatraman D, Di Federico A, Gandhi MM, Vaz VR, Nishino M, Sholl LM, Cherniack AD, [...] Awad MM
J Thorac Oncol, 18(11):1524-1537, 27 May 2023
Cited by: 8 articles | PMID: 37247843 | PMCID: PMC10913104
Add to export list Free full text in Europe PMC
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma.
Scalera S, Ricciuti B, Mazzotta M, Calonaci N, Alessi JV, Cipriani L, Bon G, Messina B, Lamberti G, Di Federico A, Pecci F, Milite S, Krasniqi E, Barba M, Vici P, Vecchione A, De Nicola F, Ciuffreda L, Goeman F, [...] Maugeri-Saccà M
Ann Oncol, 34(3):275-288, 13 Dec 2022
Cited by: 7 articles | PMID: 36526124
Add to export list
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states
Nyman J, Denize T, Bakouny Z, Labaki C, Titchen BM, Bi K, Hari SN, Rosenthal J, Mehta N, Jiang B, Sharma B, Felt K, Umeton R, Braun DA, Rodig S, Choueiri TK, Signoretti S, Van Allen EM
bioRxiv, 20 Jan 2023
Cited by: 0 articles | PPR: PPR600524
Add to export list Preprint
NF-κB-regulated VentX expression mediates tumoricidal effects of chemotherapeutics at noncytotoxic concentrations.
Le Y, Gao H, Zhu A, Felt K, Rodig S, Bleday R, Zhu Z
iScience, 25(11):105426, 22 Oct 2022
Cited by: 1 article | PMID: 36388981 | PMCID: PMC9641229
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS^G12D-mutated non-small-cell lung cancer.
Ricciuti B, Alessi JV, Elkrief A, Wang X, Cortellini A, Li YY, Vaz VR, Gupta H, Pecci F, Barrichello A, Lamberti G, Nguyen T, Lindsay J, Sharma B, Felt K, Rodig SJ, Nishino M, Sholl LM, Barbie DA, [...] Luo J
Ann Oncol, 33(10):1029-1040, 22 Jul 2022
Cited by: 34 articles | PMID: 35872166
Add to export list
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma.
Lee PC, Klaeger S, Le PM, Korthauer K, Cheng J, Ananthapadmanabhan V, Frost TC, Stevens JD, Wong AY, Iorgulescu JB, Tarren AY, Chea VA, Carulli IP, Lemvigh CK, Pedersen CB, Gartin AK, Sarkizova S, Wright KT, Li LW, [...] Keskin DB
J Clin Invest, 132(13):e151666, 01 Jul 2022
Cited by: 14 articles | PMID: 35775490 | PMCID: PMC9246387
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels.
Ricciuti B, Wang X, Alessi JV, Rizvi H, Mahadevan NR, Li YY, Polio A, Lindsay J, Umeton R, Sinha R, Vokes NI, Recondo G, Lamberti G, Lawrence M, Vaz VR, Leonardi GC, Plodkowski AJ, Gupta H, Cherniack AD, [...] Awad MM
JAMA Oncol, 8(8):1160-1168, 01 Aug 2022
Cited by: 131 articles | PMID: 35708671 | PMCID: PMC9204620
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia.
Hanna GJ, Villa A, Mistry N, Jia Y, Quinn CT, Turner MM, Felt KD, Pfaff K, Haddad RI, Uppaluri R, Rodig SJ, Woo SB, Egloff AM, Hodi FS
Cancer Res Commun, 2(5):390, 19 May 2022
Cited by: 0 articles | PMID: 36875716 | PMCID: PMC9981205
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer.
Alessi JV, Ricciuti B, Alden SL, Bertram AA, Lin JJ, Sakhi M, Nishino M, Vaz VR, Lindsay J, Turner MM, Pfaff K, Sharma B, Felt KD, Rodig SJ, Gainor JF, Awad MM
J Immunother Cancer, 9(11):e003536, 01 Nov 2021
Cited by: 47 articles | PMID: 34824161 | PMCID: PMC8627393
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial.
Ott PA, Nazzaro M, Pfaff KL, Gjini E, Felt KD, Wolff JO, Buchbinder EI, Haq R, Sullivan RJ, Lawrence DP, McDermott DF, Severgnini M, Giobbie-Hurder A, Rodig SJ, Stephen Hodi F
J Immunother Cancer, 9(11):e003318, 01 Nov 2021
Cited by: 7 articles | PMID: 34772758 | PMCID: PMC8593712
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia.
Hanna GJ, Villa A, Mistry N, Jia Y, Quinn CT, Turner MM, Felt KD, Pfaff K, Haddad RI, Uppaluri R, Rodig SJ, Woo SB, Egloff AM, Hodi FS
Cancer Res Commun, 1(1):30-40, 13 Oct 2021
Cited by: 9 articles | PMID: 36860910 | PMCID: PMC9973379
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Tumor-Immune Partitioning and Clustering (TIPC): an algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironment
Nowak J, Lau MC, Borowsky J, Väyrynen J, Haruki K, Zhao M, Costa AD, Gu S, Silva AD, Arima K, Yeong J, Felt K, Hamada T, Nishihara R, Lennerz J, Fuchs C, Wu C, Meyerhardt J, Ogino S
Research Square, 20 Sep 2021
Cited by: 0 articles | PPR: PPR397183
Add to export list Preprint v1
SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition.
Alessi JV, Ricciuti B, Spurr LF, Gupta H, Li YY, Glass C, Nishino M, Cherniack AD, Lindsay J, Sharma B, Felt KD, Rodig SJ, Cheng ML, Sholl LM, Awad MM
J Thorac Oncol, 16(7):1176-1187, 01 Jul 2021
Cited by: 51 articles | PMID: 33845210
Add to export list
Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment.
Borowsky J, Haruki K, Lau MC, Dias Costa A, Väyrynen JP, Ugai T, Arima K, da Silva A, Felt KD, Zhao M, Gurjao C, Twombly TS, Fujiyoshi K, Väyrynen SA, Hamada T, Mima K, Bullman S, Harrison TA, Phipps AI, [...] Ogino S
Clin Cancer Res, 27(10):2816-2826, 25 Feb 2021
Cited by: 39 articles | PMID: 33632927 | PMCID: PMC8127352
Add to export list Free full text in Europe PMC
Tumor-Immune Partitioning and Clustering (TIPC) algorithm reveals distinct signatures of tumor-immune cell interactions within the tumor microenvironment
Lau MC, Borowsky J, Väyrynen JP, Haruki K, Zhao M, Costa AD, Gu S, Silva Ad, Arima K, Yeong J, Felt KD, Hamada T, Nishihara R, Lennerz JK, Fuchs CS, Wu CJ, Ogino S, Nowak JA
bioRxiv, 30 May 2020
Cited by: 0 articles | PPR: PPR169192
Add to export list Preprint
Author Correction: Subsets of exhausted CD8⁺ T cells differentially mediate tumor control and respond to checkpoint blockade.
Miller BC, Sen DR, Al Abosy R, Bi K, Virkud YV, LaFleur MW, Yates KB, Lako A, Felt K, Naik GS, Manos M, Gjini E, Kuchroo JR, Ishizuka JJ, Collier JL, Griffin GK, Maleri S, Comstock DE, Weiss SA, [...] Haining WN
Nat Immunol, 20(11):1556, 01 Nov 2019
Cited by: 9 articles | PMID: 31582823 | PMCID: PMC7461603
Add to export list Free full text in Europe PMC
Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.
Nabel CS, Severgnini M, Hung YP, Cunningham-Bussel A, Gjini E, Kleinsteuber K, Seymour LJ, Holland MK, Cunningham R, Felt KD, Vivero M, Rodig SJ, Massarotti EM, Rahma OE, Harshman LC
Oncologist, 24(8):1013-1021, 14 May 2019
Cited by: 12 articles | PMID: 31088979 | PMCID: PMC6693726
Add to export list Free full text in Europe PMC
Prediction of an Upper Limit for the Fraction of Interprotein Cross-Links in Large-Scale In Vivo Cross-Linking Studies.
Keller A, Chavez JD, Felt KC, Bruce JE
J Proteome Res, 18(8):3077-3085, 17 Jul 2019
Cited by: 14 articles | PMID: 31267744 | PMCID: PMC6777711
Add to export list Free full text in Europe PMC
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal Cancer.
Gurjao C, Liu D, Hofree M, AlDubayan SH, Wakiro I, Su MJ, Felt K, Gjini E, Brais LK, Rotem A, Rosenthal MH, Rozenblatt-Rosen O, Rodig S, Ng K, Van Allen EM, Corsello SM, Ogino S, Regev A, Nowak JA, Giannakis M
Cancer Immunol Res, 7(8):1230-1236, 19 Jun 2019
Cited by: 44 articles | PMID: 31217164 | PMCID: PMC6679789
Add to export list Free full text in Europe PMC

1-25 of 30 results

1 2

Search life-sciences literature (45,104,931 articles, preprints and more)

Search results

Author Correction: Structural basis for partial agonism in 5-HT_3A receptors.

ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.

Structural basis for partial agonism in 5-HT_3A receptors.

Systematic benchmarking of imaging spatial transcriptomics platforms in FFPE tissues

Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states.

Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.

Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.

Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma.

Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states

NF-κB-regulated VentX expression mediates tumoricidal effects of chemotherapeutics at noncytotoxic concentrations.

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS^G12D-mutated non-small-cell lung cancer.

Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma.

Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels.

Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia.

Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer.

Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial.

Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia.

Tumor-Immune Partitioning and Clustering (TIPC): an algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironment

SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition.

Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment.

Tumor-Immune Partitioning and Clustering (TIPC) algorithm reveals distinct signatures of tumor-immune cell interactions within the tumor microenvironment

Author Correction: Subsets of exhausted CD8⁺ T cells differentially mediate tumor control and respond to checkpoint blockade.

Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.

Prediction of an Upper Limit for the Fraction of Interprotein Cross-Links in Large-Scale In Vivo Cross-Linking Studies.

Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal Cancer.

Partnerships & funding